Table 2.

(A) Relationship of peak stimulated growth hormone (GH) on GH-releasing hormone (GHRH)–arginine stimulation test to measures of body composition in all subjects (n = 76) using univariate and multivariate regression analyses; (B) Relationship of FT by equilibrium dialysis to measures of body composition in all subjects (n = 76) using univariate and multivariate regression analyses; (C) Relationship of peak stimulated GH on GHRH–arginine stimulation test to measures of body composition in obese subjects only (n = 50) using univariate and multivariate regression analyses; (D) Relationship of FT by equilibrium dialysis to measures of body composition in obese subjects only (n = 50) using univariate and multivariate regression analyses

	Univariate regression		Multivariate regression
	r	P	β	SE	P
(A) Peak GH (all subjects)
BMI	−0·71	<0·0001	−1·42	0·58	0·02
VAT	−0·65	<0·0001	−0·04	0·02	0·07
SAT	−0·65	<0·0001	0·003	0·02	0·86
(B) FT (all subjects)
BMI	−0·44	<0·0001	−0·005	0·007	0·48
VAT	−0·51	<0·0001	−0·0007	0·0003	0·02
SAT	−0·41	0·0002	0·00005	0·0003	0·84
(C) Peak GH (obese only)
BMI	−0·37	0·009	−0·19	0·22	0·39
VAT	−0·43	0·002	−0·02	0·007	0·04
SAT	−0·32	0·03	−0·001	0·006	0·83
(D) FT (obese only)
BMI	−0·28	0·05	−0·01	0·01	0·34
VAT	−0·39	0·006	−0·0007	0·0003	0·05
SAT	−0·19	0·19	0·0001	0·0003	0·66

VAT, visceral adipose tissue; SAT, subcutaneous adipose tissue; FT, free testosterone.